Investor mix
7 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 43% |
| Private equity | 2 | 29% |
| Other / undisclosed | 2 | 29% |
Biologic R&D for oncology; respiratory, inflammation and autoimmune; and cardiovascular and metabolic diseases
7 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 43% |
| Private equity | 2 | 29% |
| Other / undisclosed | 2 | 29% |